| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
33,516 |
17,568 |
$2.52M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
30,852 |
14,847 |
$1.38M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,897 |
3,355 |
$495K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
37,827 |
10,451 |
$407K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,021 |
2,743 |
$369K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,835 |
2,705 |
$364K |
| 96160 |
|
17,404 |
10,921 |
$282K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,662 |
1,877 |
$257K |
| 99215 |
Prolong outpt/office vis |
1,882 |
1,257 |
$230K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,123 |
1,768 |
$227K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
14,228 |
8,630 |
$194K |
| 99174 |
|
13,471 |
8,611 |
$165K |
| 96127 |
|
9,699 |
6,174 |
$147K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,045 |
1,991 |
$96K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,410 |
1,603 |
$82K |
| 99188 |
|
5,349 |
2,594 |
$61K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,702 |
1,637 |
$52K |
| 92551 |
|
9,843 |
6,411 |
$40K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,485 |
1,139 |
$26K |
| 92587 |
|
1,462 |
646 |
$22K |
| D0145 |
Oral evaluation for a patient under three years of age |
1,095 |
888 |
$22K |
| 94664 |
|
4,307 |
1,964 |
$19K |
| 94760 |
|
15,816 |
9,662 |
$19K |
| 99070 |
|
1,736 |
919 |
$17K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
156 |
85 |
$16K |
| 96161 |
|
1,654 |
683 |
$16K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
827 |
809 |
$15K |
| D1206 |
Topical application of fluoride varnish |
1,045 |
762 |
$15K |
| 87430 |
|
2,992 |
1,032 |
$12K |
| 69210 |
|
929 |
218 |
$8K |
| 36416 |
|
3,030 |
1,951 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
244 |
232 |
$6K |
| 99442 |
|
148 |
130 |
$6K |
| 90691 |
|
64 |
56 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,187 |
312 |
$4K |
| 83655 |
|
160 |
154 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
36 |
36 |
$1K |
| 0112A |
|
18 |
18 |
$720.00 |
| 0111A |
|
18 |
18 |
$720.00 |
| 90715 |
|
134 |
124 |
$153.24 |
| 36410 |
|
19 |
13 |
$149.11 |
| 87070 |
|
1,501 |
317 |
$136.80 |
| 80061 |
Lipid panel |
190 |
141 |
$25.58 |
| 81002 |
|
959 |
460 |
$12.20 |
| 85018 |
|
2,832 |
1,995 |
$6.78 |
| 90677 |
|
107 |
93 |
$5.30 |
| 90710 |
|
1,003 |
373 |
$0.10 |
| 90686 |
|
13,436 |
4,356 |
$0.10 |
| 90674 |
|
733 |
706 |
$0.10 |
| 99072 |
|
3,004 |
2,561 |
$0.00 |
| 90633 |
|
897 |
357 |
$0.00 |
| 90461 |
|
7,213 |
4,088 |
$0.00 |
| 90734 |
|
370 |
221 |
$0.00 |
| 90670 |
|
2,336 |
1,150 |
$0.00 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
1,215 |
331 |
$0.00 |
| 90648 |
|
2,584 |
1,255 |
$0.00 |
| 91311 |
|
61 |
61 |
$0.00 |
| 90681 |
|
662 |
166 |
$0.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
593 |
431 |
$0.00 |
| 90723 |
|
1,485 |
609 |
$0.00 |
| 99000 |
|
12,470 |
9,112 |
$0.00 |
| 90651 |
|
482 |
452 |
$0.00 |
| 90620 |
|
120 |
115 |
$0.00 |
| 90619 |
|
32 |
32 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
18 |
18 |
$0.00 |
| 99441 |
|
22 |
21 |
$0.00 |
| A7015 |
Aerosol mask, used with dme nebulizer |
572 |
42 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
182 |
13 |
$0.00 |